Similarly, treatment with a mAb targeting the new extracellular co-chaperone Morgana in a breast cancer model blocked cancer cell migration and inhibited metastasis as well as reduced primary tumor growth through macrophage-dependent CD8+ T-cell recruitment (Secli et al., 2021a). This evidence concerns the gene CHORDC1 and cancer.